医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02158 医渡科技

交易中 04-14 14:37:28

5.600

+0.050

+0.90%

最高5.820	最低5.520	成交量341.13万
今开5.550	昨收5.550	日振幅5.41%
总市值57.12亿	流通市值57.12亿	总股本10.20亿
成交额1,924万	换手率0.33%	流通股本10.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02158","market":"HK","secType":"STK","nameCN":"医渡科技","latestPrice":5.6,"timestamp":1776148485906,"preClose":5.55,"halted":0,"volume":3411300,"delay":0,"changeRate":0.009009009009008978,"floatShares":1019999999,"shares":1019999999,"eps":-0.12812891677437044,"marketStatus":"交易中","change":0.05,"latestTime":"04-14 14:37:28","open":5.55,"high":5.82,"low":5.52,"amount":19243438,"amplitude":0.054054,"askPrice":5.61,"askSize":2000,"bidPrice":5.6,"bidSize":18500,"shortable":3,"etf":0,"ttmEps":-0.09662531014765208,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1776154200000},"marketStatusCode":2,"adr":0,"listingDate":1610640000000,"exchange":"SEHK","adjPreClose":5.55,"openAndCloseTimeList":[[1776130200000,1776139200000],[1776142800000,1776153600000]],"volumeRatio":0.893886,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02158/tweets","defaultTab":"tweets","newsList":[{"id":"2627348603","title":"医渡科技（02158）中标海南重大公卫项目 项目金额近1300万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627348603","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627348603?lang=zh_cn&edition=full","pubTime":"2026-04-13 12:36","pubTimestamp":1776054962,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，医渡科技近期展现出强劲的业务拓展势头。两项中标，被视为公司在医疗AI大模型商业化落地及公共卫生智能化领域的双重突破。消息面上，4月9日，医渡科技举办“医渡智循”专场投资人交流会，吸引了近百位国内外知名基金及主流券商机构代表参与。基于上述积极进展，花旗银行于近日发布研报，重申对医渡科技的“买入”评级，并给出11.00港元的目标价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1518","02158","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627486415","title":"医渡科技(02158)联属公司中标省统筹区域传染病监测预警与应急指挥信息平台(海南省二期)项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2627486415","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627486415?lang=zh_cn&edition=full","pubTime":"2026-04-13 12:24","pubTimestamp":1776054272,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医渡科技 发布公告，近期，本公司的联属公司医渡云(北京)技术有限公司中标省统筹区域传染病监测预警与应急指挥信息平台项目，项目总金额约为人民币1289万元。医渡科技是驱动中国医疗体系智能化升级的核心力量，我们以智慧决策深度赋能“医、药、险、患”全产业链，致力于使精准医疗惠及每一个人。医渡科技，以自主创新的系统级智能，创造更具韧性、更富关怀、更普惠高效的医疗健康未来。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","BK1189","02158","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626193916","title":"花旗：给予医渡科技(02158)“买入”评级 目标价为11.00港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2626193916","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626193916?lang=zh_cn&edition=full","pubTime":"2026-04-10 16:30","pubTimestamp":1775809836,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，花旗发布研报称，基于净现值的分部加总估值法是评估医渡科技合理价值的最合适方法。公司各业务板块均具备可扩展的商业模式，并通过AI技术持续提升效率。目标价为11.00港元，对应加权平均资本成本为12.5%，永续增长率为3.0%。给予“买入”评级。花旗主要观点如下：医渡科技于2026年3月正式发布医渡智循公司首席执行官徐济铭、首席财务官封晓瑛及投资者关系负责人王晓炜于4月9日在北京举行产品说明会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427057.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02158","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626891521","title":"医渡科技(02158)投资者交流会：详解医疗AI核心壁垒，数十家机构密集关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2626891521","media":"智通财经","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626891521?lang=zh_cn&edition=full","pubTime":"2026-04-09 19:19","pubTimestamp":1775733597,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近期，国内AI医疗头部企业医渡科技因在医疗人工智能领域的深度布局，特别是其专为医生打造的循证AI助手“医渡智循”的推出，吸引了市场的广泛关注。“医疗AI的本质不是语言游戏，而是对疾病进展、患者状态进行建模，其核心是数据驱动的数字孪生。”同时，公司已在50多家医院部署了医院版AI产品，为后续大规模推广奠定了坚实基础。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","150261","02158","BK1189","BK1518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152790200","title":"医渡科技更新3月股份变动月报表，回购29,374,800股并行使期权","url":"https://stock-news.laohu8.com/highlight/detail?id=1152790200","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152790200?lang=zh_cn&edition=full","pubTime":"2026-04-09 19:12","pubTimestamp":1775733138,"startTime":"0","endTime":"0","summary":"医渡科技有限公司于2026年4月9日发布2026年3月股份变动月报表，报告期为截至2026年3月31日的一个月。本月公司在多个股份回购交易日共购回29,374,800股，购回价格区间约为每股HKD 5.47至HKD 5.93，相关股份均被持作库存股。此外，公司修订后的首次公开发售后股份奖励计划3月内未发行新股，仍保留16,480,050股可发行额度。公司声明遵守香港联交所《上市规则》及相关法律法规，所有本月内股份的发行与回购均获得董事会批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625496961","title":"医渡科技(02158)：联属公司中标北京肿瘤医院人工智能建设银医合作项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2625496961","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625496961?lang=zh_cn&edition=full","pubTime":"2026-04-08 06:09","pubTimestamp":1775599787,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医渡科技 发布公告，近期，公司的联属公司医渡云(北京)技术有限公司中标北京肿瘤医院人工智能建设银医合作项目，项目总金额约为人民币488万元。医渡科技是驱动中国医疗体系智能化升级的核心力量，公司以智慧决策深度赋能“医、药、险、患”全产业链，致力于使精准医疗惠及每一个人。医渡科技，以自主创新的系统级智能，创造更具韧性、更富关怀、更普惠高效的医疗健康未来。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1617","AGIX","161631","ARTY","CHAT","BK1518","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624565544","title":"文莱卫生部长到访医渡科技(02158)及AI落地医院，合作再拓新局","url":"https://stock-news.laohu8.com/highlight/detail?id=2624565544","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624565544?lang=zh_cn&edition=full","pubTime":"2026-04-01 11:10","pubTimestamp":1775013030,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近日，文莱卫生部部长伊山姆贾法尔一行到访医渡科技北京总部，并实地考察北京协和医院、北京大学肿瘤医院、清华大学北京清华长庚医院，就深化中国与文莱数字健康合作、升级文莱全民健康体系等议题展开深度交流与实地调研。文莱卫生部部长一行到访医渡科技此次访问正值文莱推进“2035宏愿”的关键时期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","AGIX","BK1518","CHAT","BK1617","AIPO","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622814785","title":"印尼卫生部部长到访医渡科技(02158) 深化战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2622814785","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622814785?lang=zh_cn&edition=full","pubTime":"2026-03-27 12:35","pubTimestamp":1774586138,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月26日，印度尼西亚卫生部部长布迪·古纳迪一行到访医渡科技北京总部，与医渡科技创始人、董事长宫如璟举行会谈。双方围绕深化中印尼数字健康合作、推动印尼国家医疗体系数字化升级等议题深入交流。此次访问正值印尼全力推进“2045黄金印尼愿景”的关键阶段。作为全球第四人口大国，印尼正将医疗健康数字化转型作为国家发展重点，在提升医疗可及性、应对慢病负担与构建韧性卫生体系方面存在迫切需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","BK1518","02158","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622261863","title":"医渡科技(02158)授权受托人根据股份奖励计划从市场购买股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2622261863","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622261863?lang=zh_cn&edition=full","pubTime":"2026-03-26 21:33","pubTimestamp":1774531980,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医渡科技(02158)发布公告，公司董事会已授权公司指示获委任管理首次公开发售后股份奖励计划的独立专业受托人根据首次公开发售后股份奖励计划的规则按现行市价于市场上购买公司股份。董事会认为，维持以具竞争力价格购入的股份储备，将提升集团在构建有效补偿与薪酬组合方面的灵活性，从而加强其吸引及留任集团持续增长及发展所需人才的能力。股份购买将根据公司需求并参考当前市况而作出。受托人购买的任何股份将由受托人根据公司与受托人订立的构成首次公开发售后股份奖励计划的信托契据所载明的目的及以计划规则而持有。所付金额(如有)将由公司内部财务资源拨付，将不会影响公司营运。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","BK1617","BK1189","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622385078","title":"中国临床循证智能能力建设计划启动 医渡智循亮相中关村论坛年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2622385078","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622385078?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:52","pubTimestamp":1774529552,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月26日，2026中关村论坛年会“世界数字健康论坛”发布一批“医疗科技创新成果”，“中国临床循证智能能力建设计划”作为其重大成果之一在会上正式启动。本次启动的“中国临床循证智能能力建设计划”正是为回应这一结构性痛点而设。在中关村论坛上启动的“中国临床循证智能能力建设计划”，不仅是一次行业协同的起点，更是中国医疗“证据驱动决策”向智能化、普惠化迈进的重要标志。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419800.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0075","BK1518","BK1189","000931","BK0239","02158","BK1617","BK0028","BK0178"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620738075","title":"回购定力不减！医渡科技(02158)3月20日再回购500余万港元 亮相CMAC提速临研AI落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2620738075","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620738075?lang=zh_cn&edition=full","pubTime":"2026-03-20 19:44","pubTimestamp":1774007054,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月20日，医渡科技延续常态化价值回购，当日耗资500余万港元回购股份，以连贯且坚定的资本动作，持续传递对公司内在价值、AI医疗长期赛道的十足信心。作为港股AI医疗回购第一股，公司年内回购表现领跑全市场，累计回购34次，累计耗资已超2.4亿港元，高频大额的回购力度树立港股医疗科技板块价值标杆，叠加高库存股占比支撑，财务稳健性与长期价值底气进一步凸显。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416757.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1189","BK1617","02158","BK1518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117838362","title":"医渡科技（02158）回购1,017,100股股份，涉资约556万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117838362","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117838362?lang=zh_cn&edition=full","pubTime":"2026-03-20 19:12","pubTimestamp":1774005155,"startTime":"0","endTime":"0","summary":"医渡科技于2026年3月20日发布翌日披露报表，公告显示公司于2026年3月20日回购普通股1,017,100股，占回购前已发行股份的约0.0996%。回购价格区间为每股港币5.39元至5.51元，合计支付港币5,560,666元。回购后，公司已发行股份数量变更为1,019,744,565股，库存股份增至52,906,100股，合计股份总数1,072,650,665股。截至本次回购前，公司已在联交所或其他证券交易所累计回购50,015,000股，占授权通过当日公司已发行股份约4.6982%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150253714","title":"医渡科技（02158）回购266.52万股股份，总额约1495.37万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1150253714","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150253714?lang=zh_cn&edition=full","pubTime":"2026-03-19 21:06","pubTimestamp":1773925582,"startTime":"0","endTime":"0","summary":"医渡科技有限公司于2026年3月19日发布翌日披露报表，公告显示公司在香港联交所场内回购2,665,200股普通股，占回购前已发行股份约0.2604%。本次回购价介乎每股5.55港元至5.65港元，合计耗资14,953,728港元。公告同时显示，此次回购基于公司于2025年8月29日通过的购回授权，剩余可回购股份数量为106,455,574股。公司强调，本次股份回购及后续安排均严格遵守香港联交所证券上市规则及相关法律法规。公告由公司董事宫盈盈正式签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620232432","title":"医渡科技(02158)3月19日斥资1495.37万港元回购266.52万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620232432","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620232432?lang=zh_cn&edition=full","pubTime":"2026-03-19 21:04","pubTimestamp":1773925491,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医渡科技(02158)发布公告，于2026年3月19日斥资1495.37万港元回购266.52万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1617","BK1518","BK1189","02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160753271","title":"医渡科技（02158）更新翌日披露报表，回购113.9万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1160753271","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160753271?lang=zh_cn&edition=full","pubTime":"2026-03-18 19:50","pubTimestamp":1773834648,"startTime":"0","endTime":"0","summary":"医渡科技有限公司于2026年3月18日发布翌日披露报表，披露公司当日通过香港联交所场内回购普通股113.9万股，占回购前已发行股份约0.1112%。该批股份每股回购价介乎每股5.66港元至5.81港元，合计支付约655.44万港元。回购后，公司已发行股份数目降至10.23426865亿股，库存股份数目增至4922.38万股，发行股份总数则维持在10.72650665亿股。公司董事会于2025年8月29日通过购回授权，授权总数为1.06455574亿股。公司表示，此次股份回购已遵守香港联交所相关上市规则及法律法规的规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620258134","title":"医渡科技(02158)3月18日斥资655.4万港元回购113.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620258134","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620258134?lang=zh_cn&edition=full","pubTime":"2026-03-18 19:50","pubTimestamp":1773834629,"startTime":"0","endTime":"0","summary":"智通财经APP讯，医渡科技(02158)发布公告，于2026年3月18日斥资655.4万港元回购113.9万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02158","BK1518","BK1189","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193324026","title":"医渡科技（02158）回购20万股股份，总额1,139,343港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193324026","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193324026?lang=zh_cn&edition=full","pubTime":"2026-03-17 19:23","pubTimestamp":1773746582,"startTime":"0","endTime":"0","summary":"医渡科技有限公司于2026年3月17日公布翌日披露报表，披露当日于香港联交所场内回购普通股20万股，占回购前公司已发行股本约0.0195%。本次回购股份的每股价格介乎每股5.66港元至5.72港元，合计支付1,139,343港元。公司早前于2025年8月29日通过回购授权，授权总数为106,455,574股。截至本次交易，已累计回购45,193,700股，占授权时已发行股本的4.2453%。公司确认已遵守香港联交所上市规则及相关法律法规。本次公告由董事宫盈盈签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156922656","title":"医渡科技（02158）回购1,908,800股，涉资约1,128万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1156922656","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156922656?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:25","pubTimestamp":1773663955,"startTime":"0","endTime":"0","summary":"医渡科技有限公司于2026年3月16日发布翌日披露报表，披露当日于香港联交所场内回购1,908,800股普通股，占回购前已发行股本约0.1859%。本次回购价格介乎每股5.84港元至5.93港元，总涉及金额约11,284,375港元。回购完成后，已发行股本由1,026,674,665股减少至1,024,765,865股；库藏股份数则由45,976,000股增至47,884,800股，总已发行股份数维持1,072,650,665股不变。截至本次购回后，累计回购股份总数为44,993,700股，占授权通过之日已发行股本的约4.2265%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02158"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619056450","title":"医渡科技(02158.HK)3月16日耗资1128.4万港元回购190.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2619056450","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619056450?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:17","pubTimestamp":1773663423,"startTime":"0","endTime":"0","summary":"格隆汇3月16日丨医渡科技(02158.HK)公告，3月16日耗资1128.4万港元回购190.9万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260316/32072304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1518","02158","BK1189","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619507034","title":"回购势头不减！医渡科技(02158)3月16日再斥资超1100万港元 高比例库存股夯实价值底气","url":"https://stock-news.laohu8.com/highlight/detail?id=2619507034","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619507034?lang=zh_cn&edition=full","pubTime":"2026-03-16 20:08","pubTimestamp":1773662935,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月16日，医渡科技持续加码股份回购，当日耗资超1100万港元，延续连日来高密度、大手笔的回购节奏，以坚定的资本动作，再度彰显管理层对公司内在价值的高度认可，以及对AI医疗赛道长期发展的充足信心。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1518","BK1617","BK1189","02158"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.084},{"period":"1month","weight":-0.0513},{"period":"3month","weight":-0.1382},{"period":"6month","weight":-0.075},{"period":"1year","weight":0.024},{"period":"ytd","weight":0.0571}],"compareEarnings":[{"period":"1week","weight":0.0217},{"period":"1month","weight":0.0077},{"period":"3month","weight":-0.0442},{"period":"6month","weight":-0.0096},{"period":"1year","weight":0.2269},{"period":"ytd","weight":0.0012}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"医渡科技有限公司是一家主要从事提供基于大数据和人工智能（AI）技术的医疗解决方案的投资控股公司。该公司主要通过三个分部运营其业务。大数据平台和解决方案分部从事提供数据智能平台及数据分析驱动的解决方案。生命科学解决方案分部从事为药物和医疗器械的全生命周期管理提供支持，涵盖从临床开发到上市后的各个阶段。健康管理平台和解决方案分部从事提供AI赋能的健康管理解决方案。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.077386},{"month":2,"riseRate":0.666667,"avgChangeRate":0.095773},{"month":3,"riseRate":0,"avgChangeRate":-0.131056},{"month":4,"riseRate":0.5,"avgChangeRate":-0.006536},{"month":5,"riseRate":0,"avgChangeRate":-0.063625},{"month":6,"riseRate":0.6,"avgChangeRate":0.067533},{"month":7,"riseRate":0.2,"avgChangeRate":-0.05605},{"month":8,"riseRate":0.2,"avgChangeRate":-0.107097},{"month":9,"riseRate":0.6,"avgChangeRate":-0.067899},{"month":10,"riseRate":0.2,"avgChangeRate":-0.069507},{"month":11,"riseRate":0.6,"avgChangeRate":0.153719},{"month":12,"riseRate":0.6,"avgChangeRate":0.017309}],"exchange":"SEHK","name":"医渡科技","nameEN":"YIDU TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医渡科技(02158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医渡科技,02158,医渡科技股票,医渡科技股票老虎,医渡科技股票老虎国际,医渡科技行情,医渡科技股票行情,医渡科技股价,医渡科技股市,医渡科技股票价格,医渡科技股票交易,医渡科技股票购买,医渡科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医渡科技(02158)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医渡科技(02158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}